First Time Loading...

Emergent BioSolutions Inc
NYSE:EBS

Watchlist Manager
Emergent BioSolutions Inc Logo
Emergent BioSolutions Inc
NYSE:EBS
Watchlist
Price: 5.27 USD -7.71% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

-82.3m
+60%
Operating Cash Flow
Growth Rates:
1 Year
+55%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
216.6m
+2%
Investing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-
-484.5m
+10%
Financing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-963%
10 Years
-

Cash Flow Statement
Emergent BioSolutions Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
19
14
22
37
35
45
60
63
88
63
48
52
58
74
86
83
67
113
100
63
42
(18)
4
55
68
170
167
305
387
299
227
231
158
97
54
(224)
(403)
(608)
(799)
(761)
(569)
Depreciation & Amortization
22
26
30
33
34
35
34
35
36
36
38
38
40
41
40
43
45
47
50
62
76
93
108
111
112
112
114
115
115
120
124
124
126
137
137
143
147
135
131
125
118
Change in Deffered Taxes
10
9
11
17
17
22
31
4
14
3
(8)
5
7
10
19
3
(6)
7
(3)
9
2
(1)
(10)
(1)
6
(4)
0
(2)
0
(2)
3
47
51
53
69
(19)
(29)
(32)
(46)
(9)
(13)
Stock-Based Compensation
11
12
12
13
14
15
15
16
17
18
19
19
18
17
16
15
18
19
20
23
23
26
28
27
27
43
47
52
56
43
43
42
42
43
44
45
42
38
31
23
0
Other Non-Cash Items
9
11
13
13
12
10
7
9
9
10
15
4
8
10
9
26
30
32
32
27
28
38
44
66
65
76
134
110
118
103
135
76
72
77
(1)
65
63
307
511
513
515
Cash Taxes Paid
0
0
0
5
0
0
0
28
0
0
0
10
0
0
0
12
0
0
0
14
0
0
0
31
4
12
87
109
107
147
80
72
75
41
38
6
18
13
21
53
49
Cash Interest Paid
0
0
0
4
0
0
0
8
0
0
0
8
0
0
0
8
0
0
0
10
0
0
0
35
7
12
14
21
26
25
34
30
30
30
30
33
43
57
63
68
68
Change in Working Capital
12
(9)
(6)
13
(24)
(44)
(38)
(66)
6
35
(22)
(46)
(60)
(25)
(37)
54
29
(52)
106
(119)
(0)
(34)
(246)
(42)
(111)
(51)
(2)
9
(137)
(194)
(251)
(156)
(127)
(70)
(56)
(31)
40
(83)
57
(75)
(134)
Cash from Operating Activities
72
N/A
50
-30%
69
+37%
112
+62%
76
-33%
67
-11%
93
+38%
45
-52%
153
+243%
148
-3%
70
-52%
54
-24%
53
-1%
109
+106%
117
+7%
208
+78%
165
-21%
146
-12%
285
+95%
42
-85%
148
+253%
77
-48%
(100)
N/A
188
N/A
141
-25%
305
+116%
413
+36%
536
+30%
483
-10%
326
-33%
237
-27%
321
+35%
279
-13%
293
+5%
202
-31%
(34)
N/A
(183)
-438%
(280)
-52%
(146)
+48%
(206)
-42%
(82)
+60%
Investing Cash Flow
Capital Expenditures
(39)
(37)
(22)
(31)
(35)
(41)
(50)
(45)
(54)
(64)
(67)
(76)
(78)
(67)
(63)
(55)
(46)
(50)
(64)
(72)
(82)
(92)
(82)
(97)
(100)
(121)
(151)
(151)
(183)
(205)
(214)
(225)
(201)
(166)
(383)
(360)
(342)
(323)
(70)
(58)
(54)
Other Items
(204)
(204)
(180)
(179)
(1)
(1)
(1)
(1)
0
0
0
0
0
0
0
(195)
0
(193)
(193)
(825)
0
(828)
(828)
0
0
0
0
0
0
0
0
0
0
0
0
(22)
0
248
248
270
0
Cash from Investing Activities
(243)
N/A
(241)
+1%
(202)
+16%
(210)
-4%
(36)
+83%
(42)
-16%
(51)
-21%
(46)
+11%
(55)
-20%
(65)
-19%
(68)
-5%
(76)
-12%
(78)
-3%
(67)
+15%
(63)
+6%
(250)
-300%
(241)
+3%
(243)
-1%
(256)
-5%
(897)
-250%
(907)
-1%
(920)
-1%
(909)
+1%
(97)
+89%
(100)
-3%
(121)
-21%
(151)
-25%
(151)
+0%
(183)
-21%
(205)
-12%
(214)
-5%
(225)
-5%
(201)
+11%
(166)
+17%
(383)
-130%
(381)
+0%
(364)
+4%
(74)
+80%
178
N/A
212
+19%
217
+2%
Financing Cash Flow
Net Issuance of Common Stock
14
16
15
14
12
17
19
26
23
27
25
17
16
7
13
(14)
(12)
(10)
(13)
16
12
12
10
8
16
27
29
32
29
0
0
(90)
(164)
(188)
(188)
(77)
(25)
9
9
10
0
Net Issuance of Debt
181
182
183
181
(0)
2
2
2
2
0
0
0
(20)
(20)
(20)
(20)
0
0
0
795
742
840
822
14
44
(56)
56
63
70
67
(33)
(36)
(28)
(31)
204
564
564
77
(196)
(543)
(494)
Other
5
5
5
4
5
2
3
6
2
8
(37)
(36)
(42)
(47)
(5)
(18)
(19)
(19)
(17)
(22)
(22)
(22)
(24)
(58)
(58)
(63)
(71)
(25)
(32)
(16)
(5)
(15)
9
3
2
(6)
2
(1)
(1)
(3)
(1)
Cash from Financing Activities
201
N/A
203
+1%
203
0%
199
-2%
17
-91%
22
+26%
24
+13%
33
+38%
27
-20%
36
+33%
(12)
N/A
(19)
-54%
(46)
-145%
(60)
-32%
(12)
+80%
(51)
-318%
(31)
+40%
(29)
+7%
(30)
-5%
789
N/A
732
-7%
829
+13%
808
-3%
(36)
N/A
3
N/A
(93)
N/A
14
N/A
70
+400%
67
-3%
59
-13%
(33)
N/A
(141)
-323%
(189)
-34%
(216)
-14%
18
N/A
481
+2 559%
541
+12%
85
-84%
(187)
N/A
(536)
-186%
(485)
+10%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
(0)
(0)
0
(0)
0
0
(0)
(0)
0
0
(0)
(1)
(0)
0
(0)
0
0
1
0
0
(1)
(1)
(1)
(1)
(0)
(0)
0
(1)
1
1
(1)
1
(1)
(1)
Net Change in Cash
30
N/A
12
-60%
70
+486%
101
+45%
56
-44%
47
-17%
67
+43%
32
-52%
125
+287%
119
-5%
(10)
N/A
(41)
-317%
(71)
-72%
(18)
+75%
42
N/A
(93)
N/A
(107)
-14%
(126)
-18%
(2)
+99%
(67)
-4 081%
(27)
+60%
(14)
+50%
(201)
-1 377%
56
N/A
44
-20%
91
+106%
276
+202%
454
+64%
366
-19%
179
-51%
(11)
N/A
(45)
-304%
(112)
-148%
(89)
+20%
(163)
-82%
66
N/A
(6)
N/A
(270)
-4 550%
(153)
+43%
(531)
-247%
(351)
+34%
Free Cash Flow
Free Cash Flow
34
N/A
13
-61%
47
+259%
82
+74%
40
-50%
26
-35%
44
+65%
(0)
N/A
99
N/A
84
-15%
3
-96%
(23)
N/A
(25)
-11%
42
N/A
54
+28%
153
+182%
119
-22%
96
-20%
221
+132%
(30)
N/A
66
N/A
(15)
N/A
(182)
-1 094%
91
N/A
41
-55%
184
+346%
262
+42%
385
+47%
300
-22%
121
-60%
23
-81%
96
+320%
78
-19%
127
+63%
(181)
N/A
(394)
-118%
(526)
-34%
(602)
-15%
(216)
+64%
(264)
-22%
(136)
+49%

See Also

Summary
EBS intrinsic value, competitors valuation, and company profile.
DCF Valuation
EBS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EBS stock valuation using valuation multiples.
Wall Street Estimates
EBS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EBS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.